175 related articles for article (PubMed ID: 34618840)
1. HSP105 expression in cutaneous malignant melanoma: Correlation with clinicopathological characteristics.
Chen KJ; Li FZ; Ye Q; Jia M; Fang S
PLoS One; 2021; 16(10):e0258053. PubMed ID: 34618840
[TBL] [Abstract][Full Text] [Related]
2. HSP105 expression in oral squamous cell carcinoma: Correlation with clinicopathological features and outcomes.
Arvanitidou S; Martinelli-Kläy CP; Samson J; Lobrinus JA; Dulguerov N; Lombardi T
J Oral Pathol Med; 2020 Aug; 49(7):665-671. PubMed ID: 32128880
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.
Muchemwa FC; Nakatsura T; Fukushima S; Nishimura Y; Kageshita T; Ihn H
Melanoma Res; 2008 Jun; 18(3):166-71. PubMed ID: 18477890
[TBL] [Abstract][Full Text] [Related]
4. Expression of Heat Shock Protein 105 in Cutaneous Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics.
Jia M; Li FZ; Ye Q; Chen KJ; Fang S
Clin Cosmet Investig Dermatol; 2021; 14():633-641. PubMed ID: 34163202
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4 T cells and CD8 T cells.
Miyazaki M; Nakatsura T; Yokomine K; Senju S; Monji M; Hosaka S; Komori H; Yoshitake Y; Motomura Y; Minohara M; Kubo T; Ishihara K; Hatayama T; Ogawa M; Nishimura Y
Cancer Sci; 2005 Oct; 96(10):695-705. PubMed ID: 16232202
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
7. Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register.
Lyth J; Falk M; Maroti M; Eriksson H; Ingvar C
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1468-1474. PubMed ID: 28419674
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma.
Muchemwa FC; Nakatsura T; Ihn H; Kageshita T
Br J Dermatol; 2006 Sep; 155(3):582-5. PubMed ID: 16911285
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of ovostatin 2 reveals its involvement in proliferation, invasion and angiogenesis of cutaneous malignant melanoma.
Huang YX; Qi J; Wang HS; Shao XB; Zeng XS; Li AM; Xu XL; Sun JF
J Dermatol; 2013 Nov; 40(11):901-10. PubMed ID: 24112097
[TBL] [Abstract][Full Text] [Related]
10. The expression of heat shock proteins 27 and 105 in squamous cell carcinoma of the tongue and relationship with clinicopathological index.
Mohtasham N; Babakoohi S; Montaser-Kouhsari L; Memar B; Salehinejad J; Rahpeyma A; Khageh-Ahmady S; Marouzi P; Firooz A; Pazoki-Toroudi H; Anvari K
Med Oral Patol Oral Cir Bucal; 2011 Sep; 16(6):e730-5. PubMed ID: 21196872
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
12. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
13. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology and prognostic factors in cutaneous malignant melanoma].
Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ
Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679
[TBL] [Abstract][Full Text] [Related]
15. Molecular oncogene markers and their significance in cutaneous malignant melanoma.
Konstadoulakis MM; Vezeridis M; Hatziyianni E; Karakousis CP; Cole B; Bland KI; Wanebo HJ
Ann Surg Oncol; 1998; 5(3):253-60. PubMed ID: 9607628
[TBL] [Abstract][Full Text] [Related]
16. Primary dermal melanoma: a unique subtype of melanoma to be distinguished from cutaneous metastatic melanoma: a clinical, histologic, and gene expression-profiling study.
Sidiropoulos M; Obregon R; Cooper C; Sholl LM; Guitart J; Gerami P
J Am Acad Dermatol; 2014 Dec; 71(6):1083-92. PubMed ID: 25262174
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92a regulates the development of cutaneous malignant melanoma by mediating FOXP1.
Sun HW; Yang GL; Wang SN; Zhang YJ; Ding JX; Zhang XN
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8991-8999. PubMed ID: 31696487
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.
Chen H; Takahara M; Oba J; Xie L; Chiba T; Takeuchi S; Tu Y; Nakahara T; Uchi H; Moroi Y; Furue M
J Dermatol Sci; 2011 Oct; 64(1):39-44. PubMed ID: 21767935
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 105 is overexpressed in a variety of human tumors.
Kai M; Nakatsura T; Egami H; Senju S; Nishimura Y; Ogawa M
Oncol Rep; 2003; 10(6):1777-82. PubMed ID: 14534695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
